These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38184954)

  • 21. Comparison of COVID-19 and seasonal influenza under different intensities of non-pharmaceutical interventions and vaccine effectiveness.
    Chen Y; Wang Z; Li F; Ma J; Zhang J; Chen Y; Zhang T
    Front Public Health; 2022; 10():973088. PubMed ID: 36238257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When do we need multiple infectious disease models? Agreement between projection rank and magnitude in a multi-model setting.
    Wade-Malone K; Howerton E; Probert WJM; Runge MC; Viboud C; Shea K
    Epidemics; 2024 Jun; 47():100767. PubMed ID: 38714099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using results from infectious disease modeling to improve the response to a potential H7N9 influenza pandemic.
    Rasmussen SA; Redd SC
    Clin Infect Dis; 2015 May; 60 Suppl 1(Suppl 1):S9-10. PubMed ID: 25878303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 healthcare demand projections: Arizona.
    Gel ES; Jehn M; Lant T; Muldoon AR; Nelson T; Ross HM
    PLoS One; 2020; 15(12):e0242588. PubMed ID: 33264308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Quixotic Task of Forecasting Peaks of COVID-19: Rather Focus on Forward and Backward Projections.
    Reis RF; Oliveira RS; Quintela BM; Campos JO; Gomes JM; Rocha BM; Lobosco M; Dos Santos RW
    Front Public Health; 2021; 9():623521. PubMed ID: 33796495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of heterogeneity: National scale data-driven agent-based modeling for the US COVID-19 Scenario Modeling Hub.
    Chen J; Bhattacharya P; Hoops S; Machi D; Adiga A; Mortveit H; Venkatramanan S; Lewis B; Marathe M
    Epidemics; 2024 Sep; 48():100779. PubMed ID: 39024889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canada in the face of the 2009 H1N1 pandemic.
    Moghadas SM; Pizzi NJ; Wu J; Tamblyn SE; Fisman DN
    Influenza Other Respir Viruses; 2011 Mar; 5(2):83-8. PubMed ID: 21306571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How different COVID-19 recovery paths affect human health, environmental sustainability, and food affordability: a modelling study.
    Maire J; Sattar A; Henry R; Warren F; Merkle M; Rounsevell M; Alexander P
    Lancet Planet Health; 2022 Jul; 6(7):e565-e576. PubMed ID: 35809586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
    Degeling C; Williams J; Carter SM; Moss R; Massey P; Gilbert GL; Shih P; Braunack-Mayer A; Crooks K; Brown D; McVernon J
    Vaccine; 2021 Jan; 39(2):255-262. PubMed ID: 33317870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responding to vaccine safety signals during pandemic influenza: a modeling study.
    Maro JC; Fryback DG; Lieu TA; Lee GM; Martin DB
    PLoS One; 2014; 9(12):e115553. PubMed ID: 25536228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An appraisal of peer-reviewed published literature on Influenza, 2000-2021 from countries in South-East Asia Region.
    Ranjan Wijesinghe P; Sharma D; Vaishnav B; Mukherjee R; Pawar P; Mohapatra A; Buddha N; Ceniza Salvador E; Kakkar M
    Front Public Health; 2023; 11():1127891. PubMed ID: 37139386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19: The Time for Collaboration Between Long-Term Services and Supports, Health Care Systems, and Public Health Is Now.
    Dawson WD; Boucher NA; Stone R; VAN Houtven CH
    Milbank Q; 2021 Jun; 99(2):565-594. PubMed ID: 33590920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Causes of Death Collaborators
    Lancet; 2024 May; 403(10440):2100-2132. PubMed ID: 38582094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study.
    Ali ST; Lau YC; Shan S; Ryu S; Du Z; Wang L; Xu XK; Chen D; Xiong J; Tae J; Tsang TK; Wu P; Lau EHY; Cowling BJ
    Lancet Glob Health; 2022 Nov; 10(11):e1612-e1622. PubMed ID: 36240828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The performance of phenomenological models in providing near-term Canadian case projections in the midst of the COVID-19 pandemic: March - April, 2020.
    Smith BA; Bancej C; Fazil A; Mullah M; Yan P; Zhang S
    Epidemics; 2021 Jun; 35():100457. PubMed ID: 33857889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of the COVID-19 pandemic and the free vaccination policy on seasonal influenza vaccination uptake among older adults in Ningbo, Eastern China.
    Ye L; Chen J; Mei Q; Sun Y; Yang T
    Hum Vaccin Immunother; 2024 Dec; 20(1):2370999. PubMed ID: 38957901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two years of COVID-19 pandemic: Framework of health interventions in a Brazilian city.
    Faiões VDS; Póvoa HCC; Thurler BA; Chianca GC; Assaf AV; Iorio NLPP
    Front Public Health; 2022; 10():1025410. PubMed ID: 36388316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PaCAR: COVID-19 Pandemic Control Decision Making via Large-Scale Agent-Based Modeling and Deep Reinforcement Learning.
    Guo X; Chen P; Liang S; Jiao Z; Li L; Yan J; Huang Y; Liu Y; Fan W
    Med Decis Making; 2022 Nov; 42(8):1064-1077. PubMed ID: 35775610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.
    Borchering RK; Viboud C; Howerton E; Smith CP; Truelove S; Runge MC; Reich NG; Contamin L; Levander J; Salerno J; van Panhuis W; Kinsey M; Tallaksen K; Obrecht RF; Asher L; Costello C; Kelbaugh M; Wilson S; Shin L; Gallagher ME; Mullany LC; Rainwater-Lovett K; Lemaitre JC; Dent J; Grantz KH; Kaminsky J; Lauer SA; Lee EC; Meredith HR; Perez-Saez J; Keegan LT; Karlen D; Chinazzi M; Davis JT; Mu K; Xiong X; Pastore Y Piontti A; Vespignani A; Srivastava A; Porebski P; Venkatramanan S; Adiga A; Lewis B; Klahn B; Outten J; Schlitt J; Corbett P; Telionis PA; Wang L; Peddireddy AS; Hurt B; Chen J; Vullikanti A; Marathe M; Healy JM; Slayton RB; Biggerstaff M; Johansson MA; Shea K; Lessler J
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):719-724. PubMed ID: 33988185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.